Related Experiment Videos

Modulation of macrophage procoagulant activity by arachidonic acid metabolites

D S Kucey1, P Y Cheung, J C Marshall

  • 1Department of Surgery, University of Toronto, Ontario, Canada.

Insights

The 5-lipoxygenase (5-LO) pathway, but not the cyclooxygenase (CO) pathway, is crucial for macrophage procoagulant activity (PCA) induction by lipopolysaccharide (LPS). Inhibiting 5-LO significantly reduces PCA, highlighting its role in host defense during infection.

Area of Science:

  • Immunology
  • Inflammation Biology
  • Hemostasis

Background:

  • Macrophage (M phi)-mediated fibrin deposition via procoagulant activity (PCA) is vital for host defense during infections.
  • Lipopolysaccharide (LPS) is a known inducer of M phi PCA, but factors influencing this activity in the inflammatory microenvironment remain unclear.

Purpose of the Study:

  • To investigate the roles of the cyclooxygenase (CO) and 5-lipoxygenase (5-LO) pathways in modulating M phi PCA induction by LPS.

Main Methods:

  • Murine peritoneal M phi were treated with CO inhibitor (indomethacin) or 5-LO inhibitor (nordihydroguaiaretic acid) before LPS exposure.
  • PCA was quantified by measuring the plasma clotting time reduction.
  • Dose-dependent inhibition and cell viability were assessed.

Main Results:

  • CO inhibition (indomethacin) did not affect LPS-induced PCA.
  • 5-LO inhibition (nordihydroguaiaretic acid) dose-dependently inhibited LPS-induced PCA (IC50 = 3 microM) without affecting cell viability.
  • NDGA also inhibited PCA induced by Escherichia coli, suggesting a general role for 5-LO.

Conclusions:

  • The 5-LO pathway plays a significant role in M phi PCA induction by LPS.
  • Targeting the 5-LO pathway may offer therapeutic strategies for modulating host response in infections.

Related Concept Videos